LONDON, Dec. 19, 2016 /PRNewswire/ --
The ever increasing rise in the cardiovascular diseases, especially the valvular diseases, has led to the discovery of innovative treatment techniques. One of the recent technological innovations include the transcatheter heart valve replacement, which involves delivering the new replacement valves without removing the diseased valve via a catheter. This newly developed procedure thus eliminates the need of an open heart surgery. The technique has emerged to prove extremely beneficial for patients with high risk for the traditional open heart surgery. The success of these innovative techniques has garnered interest from major medical devices players from across the globe.
According to a new analysis from RNCOS in "Global Transcatheter Market Outlook 2020" report, the Global Transcatheter Heart Valve Replacement Market is valued at around US$ 1.8 Billion in 2015. The evolving market size could be attributed to factors such as rising incidences of valvular heart diseases, the increasing adoption of transcatheter aortic valve replacement as an alternate to the traditional open heart surgery, and the overall improving reimbursement scenario for this new procedure.
The report segments the market based on the types of transcatheter heart valves. The transcatheter aortic valve replacement accounted for the largest share in 2015. This high share of the market is attributed to large number of transcatheter aortic procedures in the US and Europe. Also, in terms of the route of delivery, the Transfemoral approach is the most preferred one, owing to the lower mortality rate and shorter recovery time.
In terms of geography, Europe is the largest market for the transcatheter heart valve replacement market. The large share of the European market is due less stringent regulatory environment in the region, which allows faster approval and commercialization of products in Europe as compared to other regions. However, it is the US market, which is expected to witness the highest growth, largely due to increasing regulatory approvals for the transcatheter heart valves, in addition to the increasing awareness of the technologically advanced technique. The report provides information on the current scenario, market outlook on the basis of the products available, application and geography, and the future forecasts on all prominent segments of the industry till 2020. Moreover, the report also provides information about the regulatory landscapes prevailing in different regions. The number of procedures performed for transcatheter aortic valve replacement is also analyzed in the report.
The report also provides details about the pipeline analysis of the various transcatheter heart valves, which are currently in the process of getting regulatory approvals in the US and Europe. The later part of the report focuses on competitive analysis of the key market players, in terms of their market share and their product offerings. Major players operating in this market include Edwards Lifesciences, Medtronic, St. Jude, amongst others. The competitive analysis is done at each player level, including their recent developments. To provide a thorough understanding of each player's business model, the player's current and historical financials have been analyzed. On the whole, the study included in the report provides a detailed market overview, current and future scenario, and industry trends which will likely generate key interest in investors thinking about joining the industry.
Download the full report: https://www.reportbuyer.com/product/3734329/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48